INNOVA CAPTAB
|
The Current P/S Ratio of INNOVA CAPTAB is 3.82.
Share Price | ₹869.2 | Sep 23,2025 |
Market Cap | ₹4,971.5 Cr | |
Sales-TTM | ₹1,301.0 Cr | TTM-Consolidated Results |
Price/Sales | 3.82x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of INNOVA CAPTAB
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹4,971.5 Cr] as on Sep 23,2025
(/) Sales [ ₹1,301.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.82x ]
Thus, for INNOVA CAPTAB , the investors are currently willing to pay '3.82 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of INNOVA CAPTAB !
The chart below summarizes the trend in P/S Ratio of INNOVA CAPTAB over the last five years.
Historical PS (Price/Sales) ratio chart of INNOVA CAPTAB
PS Ratio Performance Analysis for INNOVA CAPTAB
- INNOVA CAPTAB 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.28x.
- INNOVA CAPTAB 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INNOVA CAPTAB 's p/e ratio peaked in Mar2025 at 4.04x.
- INNOVA CAPTAB 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does INNOVA CAPTAB 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
INNOVA CAPTAB | 1,301.0 | 3.82 | 4,971.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.28 | 391,368.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 16.64 | 160,631.0 |
CIPLA LTD | 27,811.2 | 4.44 | 123,419.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.45 | 123,641.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.26 | 109,176.0 |
MANKIND PHARMA LTD | 12,956.2 | 8.16 | 105,776.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.46 | 105,187.0 |
LUPIN LTD | 23,375.9 | 3.92 | 91,611.2 |
AUROBINDO PHARMA LTD | 32,024.8 | 2.01 | 64,474.8 |
ABBOTT INDIA LTD | 6,589.9 | 9.75 | 64,282.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs INNOVA CAPTAB 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.01x |
Max industry PS | 16.64x |
Median industry PS | 4.46x |
Average industry PS | 6.74x |
You may also like the below Video Courses